Ekso Bionics (NASDAQ:EKSO) Releases Quarterly Earnings Results, Misses Expectations By $0.04 EPS

Ekso Bionics (NASDAQ:EKSO) posted its quarterly earnings results on Monday. The company reported ($0.20) earnings per share for the quarter, missing the consensus estimate of ($0.16) by ($0.04), Yahoo Finance reports. Ekso Bionics had a negative net margin of 83.14% and a negative return on equity of 90.80%. During the same quarter in the prior year, the company posted ($0.33) EPS.

Ekso Bionics Price Performance

Shares of EKSO opened at $1.29 on Tuesday. The firm has a market capitalization of $23.09 million, a PE ratio of -1.17 and a beta of 1.61. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.49 and a quick ratio of 1.87. Ekso Bionics has a 1-year low of $0.62 and a 1-year high of $3.13. The company’s fifty day moving average price is $1.49 and its 200-day moving average price is $1.63.

Analyst Ratings Changes

A number of equities analysts recently commented on EKSO shares. HC Wainwright boosted their price objective on shares of Ekso Bionics from $9.25 to $10.00 and gave the stock a “buy” rating in a research note on Tuesday. StockNews.com raised shares of Ekso Bionics from a “sell” rating to a “hold” rating in a research note on Thursday, April 4th.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.